Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults.

Minoo MohrazMohammadreza SalehiPayam TabarsiMohsen Abbasi-KangevariSeyyed-Hadi GhamariErfan GhasemiMaryam Amini PouyaNegar RezaeiNaser AhmadiKazem HeidariMohammad-Reza MalekpourMojtaba NasiriAli Akbar AmirzargarSahar Saeedi MoghaddamBagher LarijaniHamed Hosseini

Published in: BMJ open (2022)

IRCT20201202049567N1 and IRCT20201202049567N2 for phase I and IRCT20201202049567N3 for phase II.

Keyphrases

phase ii
placebo controlled
double blind
clinical trial
sars cov
phase iii
open label
study protocol
phase ii study
respiratory syndrome coronavirus
squamous cell carcinoma
randomized controlled trial